How to protect your health in a power outage
Can juicing help you get more fruits and vegetables?
Physical therapy provides modest improvement for chronic low back pain
Scoliosis treatment: Can it help as you get older?
Kinesio taping offers only modest relief for musculoskeletal disorders
New resistance training guidance may simplify your workout
What factors speed up aging?
The problem with "classic" Lyme disease symptoms
Staying active throughout middle age may lower women's risk of dying early
Do gallstones always need treatment?
Medical Tests & Procedures Archive
Articles
Lipoprotein(a): An update on testing and treatment
High levels of Lp(a)-a fatty particle similar to LDL cholesterol-may double or triple a person's risk of a heart attack. About one in five adults may have elevated levels, which also raises the risk of stroke and aortic stenosis. Unlike LDL, which rises with age and is influenced by diet and exercise, Lp(a) remains largely constant over a person's lifetime, so a one-time test suffices for screening. Lp(a) testing is becoming more common now that five promising new Lp(a) therapies are in development.
Is it safe to stop aspirin a year after a stent?
After a heart attack or stent placement, people typically take a combination of aspirin and another antiplatelet drug. After one year, the new standard practice is to stop the aspirin, in contrast to the previous practice of stopping the other drug.
Let's not call it cancer
Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren't life-threatening. The least risky form of the disease occurs frequently with age, will not metastasize to other parts of the body, and it doesn't require any immediate treatment. So, should it even be called cancer?
A liquid biopsy for metastatic prostate cancer
Researchers are developing tools for predicting how fast prostate cancer might progress; among the most promising are those that count circulating tumor cells (CTCs) in blood samples. Research shows that high CTC counts predict poorer survival and faster disease progression. But they are also predictive for early-stage metastatic prostate cancer that still responds to hormonal therapy.
Transperineal prostate biopsies linked with lower infection risk
In a 2024 study, transperineal prostate biopsies were less likely to cause infections than traditional transrectal biopsies. Transperineal biopsies retrieve tissue samples using a thin needle inserted through the skin between the scrotum and rectum.
Pap smears or self-swabs?
Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor's office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.
How to protect your health in a power outage
Can juicing help you get more fruits and vegetables?
Physical therapy provides modest improvement for chronic low back pain
Scoliosis treatment: Can it help as you get older?
Kinesio taping offers only modest relief for musculoskeletal disorders
New resistance training guidance may simplify your workout
What factors speed up aging?
The problem with "classic" Lyme disease symptoms
Staying active throughout middle age may lower women's risk of dying early
Do gallstones always need treatment?
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up